Cite
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
MLA
Janes, Holly E., et al. “Higher T-Cell Responses Induced by DNA/RAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.” Journal of Infectious Diseases, vol. 215, no. 9, May 2017, pp. 1376–85. EBSCOhost, https://doi.org/10.1093/infdis/jix086.
APA
Janes, H. E., Cohen, K. W., Frahm, N., De Rosa, S. C., Sanchez, B., Hural, J., Magaret, C. A., Karuna, S., Bentley, C., Gottardo, R., Finak, G., Grove, D., Shen, M., Graham, B. S., Koup, R. A., Mulligan, M. J., Koblin, B., Buchbinder, S. P., Keefer, M. C., & Adams, E. (2017). Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial. Journal of Infectious Diseases, 215(9), 1376–1385. https://doi.org/10.1093/infdis/jix086
Chicago
Janes, Holly E., Kristen W. Cohen, Nicole Frahm, Stephen C. De Rosa, Brittany Sanchez, John Hural, Craig A. Magaret, et al. 2017. “Higher T-Cell Responses Induced by DNA/RAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.” Journal of Infectious Diseases 215 (9): 1376–85. doi:10.1093/infdis/jix086.